MedTrace Logo

Effect of Different Work-to-rest Ratios During Simulated Taekwondo Combat on Blood Lactate, Heart Rate and Perceptual Responses in Elite Taekwondo Athletes

NCT07395414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-09

No results posted yet for this study

Summary

This randomized cross-over study measured physiological and perceptual responses of taekwondo athletes following a free combat and combats with different W:R ratios. This study was carried out with 4 visits. The first one included body composition measurements and familiarization to the sessions and measurements. During the rest 3 visit, athletes performed simulated combats free and with 1:2 (10 sec work and 20 sec rest), and 2:1 (20 sec work and 10 sec rest) W:R ratios. During all combat sessions, athletes heart rate (HR), blood lactate (bLA), and counter-movement jump performance (CMJ) were measured at rest and at the end of each combat. HR was also measured following each set. Athletes' rating of perceived exertion (RPE) and perceived muscle soreness (PMS) were measured immediately after each combat.

Conditions

  • HIIT

Interventions

OTHER

Free combat

Athletes completed a taekwondo combat for 3 sets of 2 minutes

OTHER

1:2 work to rest ratio

Athletes completed a taekwondo combat for 3 sets of 2 mins with 1:2 work to rest ratio (10 sec work and 20 sec rest)

OTHER

2:1 work to rest ratio

Athletes completed a taekwondo combat for 3 sets of 2 minutes with 2:1 work to rest ratio (20 second work and 10 second rest)

Sponsors & Collaborators

  • Kastamonu University

    lead OTHER

Principal Investigators

  • Bayram Ceylan, PhD · Kastamonu University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-05
Primary Completion
2023-04-15
Completion
2023-06-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07395414 on ClinicalTrials.gov